Vergoeding 2018-2022 voor ATC-subgroep A10BK : Natriumglucose-cotransporter-2-remmers (sglt-2-remmers)
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| A10BK01 Dapagliflozine (Forxiga ®) | 2.952.400 | 2.900.400 | 3.344.500 | 5.403.600 | 21.032.600 |
| A10BK02 Canagliflozine (Invokana ®) | 184.570 | 323.000 | 490.490 | 668.580 | 803.720 |
| A10BK03 Empagliflozine (Jardiance ®) | 2.399.000 | 2.959.500 | 3.538.100 | 4.115.700 | 12.390.600 |
| A10BK04 Ertugliflozine (Steglatro ®) | . | 3.560 | 6.492 | 7.368 | 9.307 |
| Totaal | 5.535.970 | 6.186.460 | 7.379.582 | 10.195.248 | 34.236.227 |